Treatment of Ventricular Tachycardia Storm

Abstract:

OBJECTIVE: To investigate the clinical efficacy and safety of low-energy direct current defibrillation combined with intravenous application of β-receptor blocker in the treatment of ventricular tachycardia storm (VTS). METHODS: A total of 59 patients with VTS were randomly divided into two groups. In the control group (n = 31), intravenous administration of Lidocaine or Amiodarone and routine electrical defibrillation were performed. In the esmolol group (n = 28), intravenous administration of esmolol and low-energy electrical defibrillation were performed in addition to the same drug treatment as the control group.RESULTS: The success rate of terminating recurrent ventricular tachycardia or ventricular fibrillation was significantly higher in the esmolol group than in the control group (89.71% vs. 39.89%, P < 0.05). The necessary discharge times and average discharge energy to terminate ventricular tachycardia or ventricular fibrillation were significantly decreased in the esmolol group compared with control (5.69 ± 1.34 times vs. 8.63 ± 3.79 times, 95.32 ± 13.21J vs. 185.39 ± 25.63J, both P < 0.05). There was no significant difference in the incidence of hypotension (45.16% vs. 39.29%), sinus bradycardia (3.23% vs. 3.57%), and junctional/ventricular escape (38.71% vs. 39.29%) between the esmolol and control groups (all P > 0.05). The mortality was significantly lower in the esmolol group than in the control group (21.43%, 6/28 vs. 77.42%, 24/31, P < 0.01).CONCLUSION: Compared with conventional treatment, intravenous administration of a β-receptor blocker combined with low-energy electrical defibrillation could be a safe and effective therapy to treat VTS.

• Periodical: Applied Mechanics and Materials (Volume 140)
• Pages: 244-247
• DOI: https://doi.org/10.4028/www.scientific.net/AMM.140.244
• Online since: November 2011
• Authors: Zhao Heng Lin
• Keywords: Direct Current Electrical Defibrillation, Low Energy, Ventricular Tachycardia Storm, β-Receptor Blocker

References

[1] Zhihong Zhao, Jihong Guo, Xuebing Li, Explanation of ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death,Chinese Journal of Cardiac Pacing and Electrophysiology.30(2006)398-407.

DOI: 10.1161/circulationaha.106.178104

[2] Rengao Ye, Zhaiying Lu, Diagnosis and Treatment of Arrhythmia, sixth ed, Internal Medicine, The People's Health Publishing House, Peking,2005,203-207.

[3] Zipes DP, Camm AJ, Borggrefe M, et al, ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death, JACC. 48(2006), e247–346.

DOI: 10.1007/978-1-908517-31-9_19

[4] Ping Zhang,Sympathetic storm,Journal of Clinical Electrocardiology.26(2007)74-75.

[5] Nademanee K,Taylor R, Bailey WE, et al, Treating electrical storm. sympathetic blockade versus advanced cardiac life support guided therapy,Circulation. 102（2000）742-748.

DOI: 10.1161/01.cir.102.7.742

[6] Duan Lu,Diagnosis and treatment of ventricular arrhythmias,Clinical Education of General Practice.6(2008)268-273.

[7] Zengrui Chen, Jinnv Xu,Jinxia Chen,et al, Attack mode and clinical interference of tachycardia, Journal of Clinical Electrocardiology. 25(2006)80-84.

[8] Jihong Guo, β-receptor blocker should be the basic medicine of tachycardia,Chinese Journal of Cardiac Pacing and Electrophysiology. 29(2005)331-334.

[9] Jun Zhu, Management of malignant arrhythmia,Continuing Medical Education.10(2006)15-18 .